scholarly journals FRI0059 The efficacy and safety of pegylated recombinant methionyl human soluble tumour necrosis factor receptor type i (peg stnf-ri; p55) in a randomised, placebo-controlled, clinical study of patients with rheumatoid arthritis (ra)

2001 ◽  
Author(s):  
M Schiff ◽  
D Furst ◽  
R Fleischmann ◽  
M Macri ◽  
T Joh ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Clinical Study ◽  
Tumour Necrosis Factor ◽  
Tumour Necrosis ◽  
Receptor Type ◽  
Tumour Necrosis Factor Receptor ◽  
Type I ◽  
Efficacy And Safety ◽  
Controlled Clinical Study ◽  
Necrosis Factor

scholarly journals Soluble tumour necrosis factor receptor type II and survival in colorectal cancer

2016 ◽  
Vol 114 (9) ◽  
pp. 995-1002 ◽  
Author(s):  
Ana Babic ◽  
Sonali M Shah ◽  
Mingyang Song ◽  
Kana Wu ◽  
Jeffrey A Meyerhardt ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Tumour Necrosis Factor ◽  
Tumour Necrosis ◽  
Receptor Type ◽  
Tumour Necrosis Factor Receptor ◽  
Type Ii ◽  
Necrosis Factor
Sign in / Sign up

Export Citation Format

Share Document